课题基金 / 基金详情

Molecular Biological Study on Mechanism of Neuronal Cell Death and Establishment of New Therapy in Glaucoma

Molecular Biological Study on Mechanism of Neuronal Cell Death and Establishment of New Therapy in Glaucoma
青光眼神经细胞死亡机制的分子生物学研究及新疗法的建立
批准号:
12671699
负责人:
ABE Haruki
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001

项目摘要

项目成果

ABE Haruki的其他基金

相似基金

相关文献

中文摘要
翻译
细胞死亡被认为是由谷氨酸刺激视网膜神经节细胞和内核层细胞上的n -甲基-d-天冬氨酸(NMDA)受体引起的。利用敲除小鼠来阐明NMDA受体NR2A和NR2B亚基的作用。采用野生型和NR2A和NR2B亚基敲除小鼠。眼压升高至120mmHg诱导短暂性视网膜缺血。在野生型小鼠中,14天后视网膜神经节细胞全部消失。内核层细胞数量减少。内丛状层厚度减小。相比之下,在NR2A亚基敲除小鼠中,视网膜似乎是正常的,没有受到损伤。而NR2B亚基敲除小鼠也表现出相同的趋势。这些结果提示该亚基可能在缺血再灌注引起的视网膜细胞死亡中起直接作用。定量测定实验性高眼压模型大鼠视网膜内脑源性神经营养因子(BDNF)水平。为了诱导单侧IOP升高,我们使用了Ueda等人(1998)开发的模型。同伴的眼睛作为对照。眼压测定采用气压计。在IOP高于22 mmHg持续1、2、4和12周后,分别从实验眼和对照眼中取出视网膜作为样本。采用酶联免疫吸附法定量BDNF蛋白水平。在IOP升高1、2、4和12周后,与对照组相比,高血压眼的视网膜BDNF水平分别为277%、102%、59%和24%。本研究阐明了实验性高眼压模型大鼠视网膜中BDNF水平的显著改变。
英文摘要
Cell death has been thought to be induced by glutamate that stimulates the N-methyl-d-aspatate (NMDA) receptor present on retinal ganglion cells and on cells in the inner nuclear layer. Knock out mice were used to elucidate the role of the NR2A and NR2B subunit of the NMDA receptor. Wild type and NR2A and NR2B subunit knock out mice were used. Transient retinal ischemia was induced by raising intraocular pressure (IOP) to 120mmHg. In the Wild type mice, all the retinal ganglion cells were lost after 14 days. The number of cells in the inner nuclear layer was decreased. The thickness of the inner plexiform layer was reduced. By contrast, the retina appeared to be normal, unaffected by the insult in the NR2A subunit knockout mice. While the NR2B subunit knock out mice also showed the same tendency. These results suggest that the subunit may have a direct role in the retinal cell death induced by ischemia-reperfusion.We quantifies the level of brain-derived neurotrophic factor (BDNF) in the retina of experimental ocular hypertension model rat. To induce unilateral IOP elevation, we used a model developed by Ueda et al. (1998). Fellow eyes were served as control. IOP was measured by pneumatonometer. After the duration of IOP elevation above 22 mmHg for 1, 2, 4 and 12 weeks, retinas were dissected out from both experimental and control eyes and used as samples. To quantify BDNF protein level, we used enzyme-linked immunosorbant assay. Retinal BDNF levels of hypertensive eye compared to control after 1, 2, 4 and 12 weeks of IOP elevation were 277%, 102%, 59% and 24%, respectively. This study clarifies that BDNF levels were dramatically altered in the retina of experimental ocular hypertension model rat.
期刊论文(45)
专著(0)
科研奖励(0)
会议论文
Haruki Abe: "Glaucoma. Computer analysis of the image of the eye with glaucoma: How to evaluate the results"Ophthalmology. 42. 1577-1584 (2000)
阿部春树:“青光眼。青光眼眼睛图像的计算机分析:如何评估结果”眼科。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
福地健郎,阿部春樹: "非穿孔性線維柱帯切除術の成績と問題点"日本眼科紀要. 51. 852-856 (2000)
Takeo Fukuchi、Haruki Abe:“非穿透性小梁切除术的结果和问题”日本眼科通报 51. 852-856 (2000)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
37
    The Research for Elucidation of Molecular Mechanism of Glaucomatous Optic Neuropathy and Development of Efficacious Treatment
    • 批准号:
      17390466
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.05万
    • 财政年份:
      2005
    • 负责人:
      ABE Haruki
    • 依托单位:
    Elucidation for pathogenic mechanism of glaucomatous optic neuropathy and retinal ganglion cell death
    • 批准号:
      15390526
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.69万
    • 财政年份:
      2003
    • 负责人:
      ABE Haruki
    • 依托单位:
    Clinical and cell biological investigations into mechanisms of glaucoma induced optic nerve cell death.
    • 批准号:
      10671635
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.3万
    • 财政年份:
      1998
    • 负责人:
      ABE Haruki
    • 依托单位:
    国内基金
    海外基金
    双硫仑结合并抑制谷氨酸脱氢酶1活性调节Th17/Treg细胞平衡的作用与机制探究
    • 批准号:
      82371755
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      王秦兰
    • 依托单位:
    石斛有效成分毛兰素靶向GGT7-GSH/Glutamate信号轴增强索拉非尼诱导的铁死亡逆转肝癌索拉非尼耐药的机制研究
    • 批准号:
      --
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      30万元
    • 批准年份:
      2022
    • 负责人:
      陈鹏
    • 依托单位:
    孕激素通过下丘脑Glutamate信号通路抑制LH峰的机制研究
    • 批准号:
      82001502
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      24.0万元
    • 批准年份:
      2020
    • 负责人:
      刘亚丽
    • 依托单位:
    BF区GABA-Glutamate-Ach神经微环路在麻醉-觉醒调控中的作用机制研究